Items where authors include "Moss, L."

Article

Brown, S.R., Hall, A., Buckley, H.L. et al. (9 more authors) (2019) Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial. BMC Cancer, 19 (1). 582. ISSN 1471-2407

Tappenden, P. orcid.org/0000-0001-6612-2332, Carroll, C. orcid.org/0000-0002-6361-6182, Hamilton, J. orcid.org/0000-0003-3326-9842 et al. (5 more authors) (2019) Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health Technology Assessment, 23 (8). pp. 1-144. ISSN 1366-5278

Wadsley, J., Gregory, R., Flux, G. et al. (6 more authors) (2017) SELIMETRY- a multicentre I-131 dosimetry trial: a clinical perspective. The British Journal of Radiology, 90 (1073). 20160637. ISSN 0007-1285

Jones, A.M., Howarth, K.M., Martin, L. et al. (21 more authors) (2012) Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. Journal of Medical Genetics, 49 (3). pp. 158-163. ISSN 0022-2593